"Our urologists have been helping patients in Minnesota feel better for decades. We treat a full range of urologic conditions such as: Prostate Cancer (from diagnosis to advanced-stage treatment) Female Urinary Incontinence Kidney Stones Erectile Dysfunction Overactive Bladder (OAB) Urinary Retention Enlarged Prostate (BPH) Low Testosterone (Low T) Pelvic Prolapse Hematuria (Blood in urine) Kidney Cancer Bladder Cancer Urinary Tract Infection And perform urology procedures like: Vasectomy Vasectomy Reversal Prostate exams / PSA tests Prostate Cancer Robotic Surgery (prostatectomy) Lithotripsy UroLift for BPH Rezum for BPH Interstim for OAB Botox for OAB Circumcision"

During the past decade, Metro Urology conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 4 clinical trials were completed, i.e. on average, 26.7% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Metro Urology" #1 sponsor was "ASTORA Women's Health" with 2 trials, followed by "FemPulse Corporation" with 2 trials sponsored, "MedtronicNeuro" with 2 trials sponsored, "Spinal Singularity" with 2 trials sponsored and "Urotronic Inc." with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Metro Urology" #1 collaborator was "ClinLogix. LLC" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Metro Urology" are "Bladder Cancer" (2 trials), "Neurogenic Bladder" (2 trials), "Overactive Bladder" (2 trials), "Pelvic Organ Prolapse" (2 trials) and "Urethral Stricture" (2 trials). Many other conditions were trialed in "Metro Urology" in a lesser frequency.

Most popular intervention types in "Metro Urology" are "Device" (15 trials), "Procedure" (4 trials), "Drug" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Native Tissue Repair for pelvic organ prolapse" (2 trials), "Bladder EpiCheck Urine Test" (1 trials), "C2P" (1 trials), "Cetrelimab" (1 trials) and "Connected Urinary Catheter" (1 trials). Other intervention names were less common.

The vast majority of trials in "Metro Urology" are 7 trials for "All" genders, 7 trials for "Male" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "Metro Urology". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Metro Urology, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Metro Urology, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 13 trials that are defined as “Not Applicable".

Metro Urology has several departments that took part in Clinical trials: "Metro Urology" - 3 trials